Eastgate Biotech Corp Sales and Excise Tax Payable, Current
Eastgate Biotech Corp had Sales and Excise Tax Payable, Current of $108.35 thousand as of 2016-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:SalesAndExciseTaxPayableCurrent · last filed 2018-03-01
- 2016-12-31: Sales and Excise Tax Payable, Current $108.35K.
- 2016-09-30: Sales and Excise Tax Payable, Current $98.28K.
- 2016-06-30: Sales and Excise Tax Payable, Current $95.15K.
- 2016-03-31: Sales and Excise Tax Payable, Current $93.03K.
| Period end | Sales and Excise Tax Payable, Current |
|---|---|
| 2016-12-31 | $108.35K 10-K · filed 2018-03-01 |
| 2016-09-30 | $98.28K 10-Q/A · filed 2018-03-01 |
| 2016-06-30 | $95.15K 10-Q/A · filed 2018-03-01 |
| 2016-03-31 | $93.03K 10-Q/A · filed 2018-03-01 |
| 2015-12-31 | $79.68K 10-K · filed 2018-03-01 |
| 2014-03-31 | $14.80K 10-Q/A · filed 2014-05-19 |